Adam O'Dell, Author at Money & Markets, LLC

Author: Adam O'Dell

Be a Genomics Landlord With One High-Growth Biotech REIT

Posted by Adam O'Dell | Sep 3, 2021 | Investing

Genomics has true potential, and that opens up many avenues to invest in this mega trend. Here’s a high-growth biotech REIT worth a look.

Posted by Adam O'Dell | Aug 30, 2021 | Investing

The ARK Innovation ETF (NYSE: ARKK) holds some of the most profitable tech stocks, but how does it stack up in Green Zone Ratings?

Posted by Adam O'Dell | Aug 27, 2021 | Markets

Large-cap biotech stocks have enjoyed a nice run up thanks to the COVID-19 vaccine race. Here’s why that’s great news for small caps.

Posted by Adam O'Dell | Aug 23, 2021 | Investing

Tesla Inc. (Nasdaq: TSLA) and CEO Elon Musk face a tough road ahead. That opens the door for some other electric vehicle stocks to shine.

Posted by Adam O'Dell | Aug 20, 2021 | Investing

The U.S. just approved COVID-19 booster shots. It will be a boon for some stocks, but there are even bigger medical trends to buy into now.